FARMACOSMO SPA (COSMO.MI) Fundamental Analysis & Valuation

BIT:COSMO • IT0005487670

Current stock price

0.5 EUR
+0.02 (+4.17%)
Last:

This COSMO.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. COSMO.MI Profitability Analysis

1.1 Basic Checks

  • COSMO had negative earnings in the past year.
  • COSMO had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: COSMO reported negative net income in multiple years.
  • COSMO had negative operating cash flow in 4 of the past 5 years.
COSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFCOSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

  • The Return On Assets of COSMO (-16.93%) is worse than 88.89% of its industry peers.
  • COSMO has a Return On Equity of -65.88%. This is amonst the worse of the industry: COSMO underperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -16.93%
ROE -65.88%
ROIC N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
COSMO.MI Yearly ROA, ROE, ROICCOSMO.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • COSMO has a Gross Margin of 5.88%. This is amonst the worse of the industry: COSMO underperforms 87.04% of its industry peers.
  • COSMO's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for COSMO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
COSMO.MI Yearly Profit, Operating, Gross MarginsCOSMO.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. COSMO.MI Health Analysis

2.1 Basic Checks

  • COSMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for COSMO remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for COSMO has been increased compared to 5 years ago.
  • Compared to 1 year ago, COSMO has a worse debt to assets ratio.
COSMO.MI Yearly Shares OutstandingCOSMO.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
COSMO.MI Yearly Total Debt VS Total AssetsCOSMO.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of 1.78, we must say that COSMO is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of COSMO (1.78) is comparable to the rest of the industry.
  • COSMO has a Debt/Equity ratio of 0.84. This is a neutral value indicating COSMO is somewhat dependend on debt financing.
  • COSMO has a Debt to Equity ratio of 0.84. This is in the lower half of the industry: COSMO underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 1.78
ROIC/WACCN/A
WACC6.8%
COSMO.MI Yearly LT Debt VS Equity VS FCFCOSMO.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

  • COSMO has a Current Ratio of 1.22. This is a normal value and indicates that COSMO is financially healthy and should not expect problems in meeting its short term obligations.
  • COSMO has a Current ratio (1.22) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.50 indicates that COSMO may have some problems paying its short term obligations.
  • COSMO's Quick ratio of 0.50 is in line compared to the rest of the industry. COSMO outperforms 40.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.5
COSMO.MI Yearly Current Assets VS Current LiabilitesCOSMO.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. COSMO.MI Growth Analysis

3.1 Past

  • COSMO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.41%.
  • COSMO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.95%.
  • COSMO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.99% yearly.
EPS 1Y (TTM)-98.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.3%
Revenue 1Y (TTM)-12.95%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-14.57%

3.2 Future

  • Based on estimates for the next years, COSMO will show a very strong growth in Earnings Per Share. The EPS will grow by 127.30% on average per year.
  • The Revenue is expected to grow by 13.48% on average over the next years. This is quite good.
EPS Next Y450%
EPS Next 2Y127.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
COSMO.MI Yearly Revenue VS EstimatesCOSMO.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
COSMO.MI Yearly EPS VS EstimatesCOSMO.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 0.15 0.2

More info and screens

Find the best growth stocksShow best growing peers

4

4. COSMO.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • COSMO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 2.55, the valuation of COSMO can be described as very cheap.
  • COSMO's Price/Forward Earnings ratio is rather cheap when compared to the industry. COSMO is cheaper than 96.30% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. COSMO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 2.55
COSMO.MI Price Earnings VS Forward Price EarningsCOSMO.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSMO.MI Per share dataCOSMO.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • COSMO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as COSMO's earnings are expected to grow with 127.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y127.3%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COSMO.MI Dividend Analysis

5.1 Amount

  • COSMO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COSMO.MI Fundamentals: All Metrics, Ratios and Statistics

FARMACOSMO SPA

BIT:COSMO (3/23/2026, 7:00:00 PM)

0.5

+0.02 (+4.17%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.8%
Inst Owner ChangeN/A
Ins Owners15.29%
Ins Owner ChangeN/A
Market Cap17.38M
Revenue(TTM)58.27M
Net Income(TTM)-4.83M
AnalystsN/A
Price Target1.35 (170%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)625%
EPS NY rev (3m)625%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.55
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 2.37
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0.2
Fwd EY39.14%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS1.68
BVpS0.21
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.93%
ROE -65.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.88%
FCFM N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
F-Score2
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.2%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.5
Altman-Z 1.78
F-Score2
WACC6.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.3%
EPS Next Y450%
EPS Next 2Y127.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.95%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-14.57%
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year275.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.82%
OCF growth 3YN/A
OCF growth 5YN/A

FARMACOSMO SPA / COSMO.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FARMACOSMO SPA (COSMO.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to COSMO.MI.


Can you provide the valuation status for FARMACOSMO SPA?

ChartMill assigns a valuation rating of 4 / 10 to FARMACOSMO SPA (COSMO.MI). This can be considered as Fairly Valued.


What is the profitability of COSMO stock?

FARMACOSMO SPA (COSMO.MI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for COSMO stock?

The Earnings per Share (EPS) of FARMACOSMO SPA (COSMO.MI) is expected to grow by 450% in the next year.